SCHEMBL2552095

SCHEMBL2552095

CC[N+](CC)(CC)CCNc1cccc2c1C(=O)c1cccc(NCC[N+](CC)(CC)CC)c1C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 2/20 0.51
▸ FGB P02675 1/20 0.51
▸ MMP14 P50281 1/20 0.51
▸ TERT O14746 8/20 0.49
▸ MEN1 O00255 6/20 0.47
▸ KMT2A Q03164 6/20 0.47
▸ MAPT P10636 4/20 0.47
▸ POLB P06746 4/20 0.47
▸ EGFR P00533 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ BLM P54132 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ RAD52 P43351 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RAB9A P51151 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876751 0.96 MAPT (0.54) NSD2FGBMMP14TERTMEN1
SCHEMBL14876259 0.95 TERT (0.50) NSD2FGBMMP14TERTMEN1
SCHEMBL14876513 0.91 NSD2 (0.47) NSD2FGBMMP14TERTMEN1
SCHEMBL14876929 0.88 MEN1 (0.55) NSD2FGBMMP14TERTMEN1
SCHEMBL9364767 0.85 NSD2 (0.49) NSD2FGBMMP14TERTMEN1
SCHEMBL20334201 0.82 CYP1A2 (0.43) NSD2FGBMMP14TERTMEN1
SCHEMBL6372565 0.82 NSD2 (0.58) NSD2FGBMMP14TERTMEN1
SCHEMBL9369089 0.81 MAPT (0.54) NSD2FGBMMP14TERTMEN1
SCHEMBL9363883 0.81 TERT (0.51) NSD2FGBMMP14TERTMEN1
SCHEMBL14876573 0.80 MAPT (0.57) NSD2FGBMMP14TERTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11255761-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2022-02-22 — — US disclosed
EP-3366667-B1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING NUCLEIC ACID BIOSTATUS LTD (GB) 2021-02-17 — — EP disclosed
EP-2556047-B1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LTD (GB) 2018-06-06 — — EP disclosed
US-20150268142-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LIMITED (GB) 2015-09-24 — — US disclosed
US-9051467-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2015-06-09 — — US disclosed
US-20130101994-A1 Method of Analysing a Cell or Other Biological Material Containing a Nucleic Acid BIOSTATUS LIMITED (GB) 2013-04-25 — — US disclosed
EP-2556047-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID Biostatus Limited (GB) 2013-02-13 — — EP disclosed
WO-2011124927-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LIMITED (GB) 2011-10-13 — — WO disclosed
Send feedback